CTS Capital
Asia, Liaoning, China, Chaoyang'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
CTS Capital is a healthcare-focused fund investing in the top players of the medical vertical sector.
Investor Profile
CTS Capital has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in China, Hong Kong.
- Strong thematic focus on Health Care, Medical, Biotechnology.
Stage Focus
- Series B (25%)
- Series Unknown (25%)
- Series A (25%)
- Series C (25%)
Country Focus
- China (75%)
- Hong Kong (25%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Clinical Trials
- Precision Medicine
- Medical Device
- Oncology
- Biopharma
- Life Science
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
